When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

Women whose breast cancers need estrogen to grow are often treated for five or more years with medications to lower estrogen production or block its effects. Broadly known as endocrine therapy, the ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

The new drug is meant to treat specific types of advanced breast cancer which are resistant to hormone therapy.

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

such as a hormone therapy drug. Your doctor may recommend hormone therapy if you have platinum-resistant endometrial cancer that’s progesterone receptor (PR) positive, estrogen receptor (ER ...

Your doctor may recommend chemo, hormone, or targeted therapy. You may receive a combination of therapies or something else entirely. Oncology (cancer) drugs include a range of therapies and ...

Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.

Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

Discover why male breast cancer cases are rising, learn essential warning signs most men miss, and understand new treatment options that could save lives.

On January 17, 2025, the Food and Drug Administration (FDA ... marks a significant advancement in the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 ...